Atricure Stock Total Asset

ATRC Stock

USD 36.17 0.38 1.06%

AtriCure fundamentals help investors to digest information that contributes to AtriCure's financial success or failures. It also enables traders to predict the movement of AtriCure Stock. The fundamental analysis module provides a way to measure AtriCure's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AtriCure stock.

	Last Reported	Projected for Next Year
Total Assets	613.9 M	644.6 M
Intangibles To Total Assets	0.49	0.26

The current year's Total Assets is expected to grow to about 644.6 M, whereas Intangibles To Total Assets are forecasted to decline to 0.26.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

AtriCure Company Total Asset Analysis

AtriCure's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Total Asset

Tangible Assets

+

Intangible Assets

More About Total Asset | All Equity Analysis

Current AtriCure Total Asset

613.93 M

Most of AtriCure's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AtriCure is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

AtriCure Total Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for AtriCure is extremely important. It helps to project a fair market value of AtriCure Stock properly, considering its historical fundamentals such as Total Asset. Since AtriCure's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of AtriCure's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of AtriCure's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Retained Earnings	Total Liab	Accounts Payable	Common Stock	Property Plant Equipment	Net Debt	Net Receivables	Total Current Assets	Long Term Debt	Good Will	Short Term Investments	Short Term Debt	Intangible Assets	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.96	-0.95	0.77	0.84	0.85	0.88	0.5	0.83	0.94	0.96	0.98	0.71	0.42	0.73	-0.32	0.5	0.88	0.92	0.37	0.4	0.89	0.86	0.82
Total Stockholder Equity	0.96		-0.93	0.57	0.89	0.81	0.9	0.32	0.9	0.94	0.93	0.95	0.61	0.34	0.52	-0.3	0.72	0.83	0.92	0.46	0.37	0.94	0.84	0.91
Retained Earnings	-0.95	-0.93		-0.71	-0.88	-0.89	-0.91	-0.43	-0.89	-0.93	-0.94	-0.94	-0.62	-0.42	-0.67	0.51	-0.52	-0.88	-0.9	-0.25	-0.34	-0.84	-0.81	-0.79
Total Liab	0.77	0.57	-0.71		0.41	0.72	0.54	0.78	0.39	0.64	0.73	0.72	0.73	0.48	0.98	-0.29	-0.13	0.78	0.68	0.15	0.38	0.53	0.64	0.36
Accounts Payable	0.84	0.89	-0.88	0.41		0.69	0.93	0.09	0.98	0.81	0.85	0.9	0.28	0.08	0.39	-0.39	0.68	0.7	0.78	0.2	0.26	0.79	0.64	0.86
Common Stock	0.85	0.81	-0.89	0.72	0.69		0.79	0.5	0.69	0.76	0.79	0.79	0.62	0.42	0.68	-0.55	0.4	0.87	0.91	0.4	0.4	0.72	0.67	0.57
Property Plant Equipment	0.88	0.9	-0.91	0.54	0.93	0.79		0.27	0.93	0.81	0.88	0.92	0.37	0.11	0.55	-0.33	0.57	0.81	0.83	0.22	0.42	0.75	0.64	0.76
Net Debt	0.5	0.32	-0.43	0.78	0.09	0.5	0.27		0.09	0.31	0.55	0.44	0.54	0.25	0.73	-0.21	-0.28	0.68	0.44	0.41	0.1	0.33	0.35	0.08
Net Receivables	0.83	0.9	-0.89	0.39	0.98	0.69	0.93	0.09		0.83	0.86	0.89	0.3	0.15	0.36	-0.34	0.72	0.72	0.79	0.19	0.21	0.8	0.67	0.87
Total Current Assets	0.94	0.94	-0.93	0.64	0.81	0.76	0.81	0.31	0.83		0.89	0.91	0.77	0.59	0.6	-0.3	0.63	0.78	0.88	0.24	0.36	0.9	0.95	0.87
Long Term Debt	0.96	0.93	-0.94	0.73	0.85	0.79	0.88	0.55	0.86	0.89		0.97	0.6	0.3	0.67	-0.32	0.49	0.92	0.89	0.39	0.26	0.89	0.81	0.82
Good Will	0.98	0.95	-0.94	0.72	0.9	0.79	0.92	0.44	0.89	0.91	0.97		0.57	0.27	0.68	-0.29	0.52	0.87	0.9	0.33	0.35	0.88	0.8	0.85
Short Term Investments	0.71	0.61	-0.62	0.73	0.28	0.62	0.37	0.54	0.3	0.77	0.6	0.57		0.84	0.69	-0.18	0.23	0.61	0.67	0.27	0.4	0.64	0.87	0.47
Short Term Debt	0.42	0.34	-0.42	0.48	0.08	0.42	0.11	0.25	0.15	0.59	0.3	0.27	0.84		0.44	-0.24	0.15	0.3	0.38	-0.01	0.18	0.36	0.66	0.23
Intangible Assets	0.73	0.52	-0.67	0.98	0.39	0.68	0.55	0.73	0.36	0.6	0.67	0.68	0.69	0.44		-0.24	-0.18	0.73	0.63	0.02	0.46	0.44	0.59	0.28
Current Deferred Revenue	-0.32	-0.3	0.51	-0.29	-0.39	-0.55	-0.33	-0.21	-0.34	-0.3	-0.32	-0.29	-0.18	-0.24	-0.24		-0.12	-0.31	-0.3	-0.08	-0.18	-0.22	-0.22	-0.19
Net Tangible Assets	0.5	0.72	-0.52	-0.13	0.68	0.4	0.57	-0.28	0.72	0.63	0.49	0.52	0.23	0.15	-0.18	-0.12		0.35	0.58	0.43	0.09	0.73	0.56	0.81
Long Term Debt Total	0.88	0.83	-0.88	0.78	0.7	0.87	0.81	0.68	0.72	0.78	0.92	0.87	0.61	0.3	0.73	-0.31	0.35		0.92	0.4	0.24	0.8	0.74	0.65
Capital Surpluse	0.92	0.92	-0.9	0.68	0.78	0.91	0.83	0.44	0.79	0.88	0.89	0.9	0.67	0.38	0.63	-0.3	0.58	0.92		0.46	0.36	0.91	0.84	0.8
Long Term Investments	0.37	0.46	-0.25	0.15	0.2	0.4	0.22	0.41	0.19	0.24	0.39	0.33	0.27	-0.01	0.02	-0.08	0.43	0.4	0.46		0.03	0.55	0.25	0.38
Short Long Term Debt	0.4	0.37	-0.34	0.38	0.26	0.4	0.42	0.1	0.21	0.36	0.26	0.35	0.4	0.18	0.46	-0.18	0.09	0.24	0.36	0.03		0.23	0.37	0.19
Net Invested Capital	0.89	0.94	-0.84	0.53	0.79	0.72	0.75	0.33	0.8	0.9	0.89	0.88	0.64	0.36	0.44	-0.22	0.73	0.8	0.91	0.55	0.23		0.88	0.94
Net Working Capital	0.86	0.84	-0.81	0.64	0.64	0.67	0.64	0.35	0.67	0.95	0.81	0.8	0.87	0.66	0.59	-0.22	0.56	0.74	0.84	0.25	0.37	0.88		0.82
Capital Stock	0.82	0.91	-0.79	0.36	0.86	0.57	0.76	0.08	0.87	0.87	0.82	0.85	0.47	0.23	0.28	-0.19	0.81	0.65	0.8	0.38	0.19	0.94	0.82

Click cells to compare fundamentals

AtriCure Total Asset Historical Pattern

Today, most investors in AtriCure Stock are looking for potential investment opportunities by analyzing not only static indicators but also various AtriCure's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of AtriCure total asset as a starting point in their analysis.

AtriCure Total Asset

Timeline

Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.

Competition

Predict AtriCure

Total Assets Over Time

AtriCure Total Assets

Total Assets

644.63 Million

At present, AtriCure's Total Assets are projected to increase significantly based on the last few years of reporting.

Based on the latest financial disclosure, AtriCure has a Total Asset of 613.93 M. This is 91.84% lower than that of the Health Care Equipment & Supplies sector and 81.46% lower than that of the Health Care industry. The total asset for all United States stocks is 97.92% higher than that of the company.

AtriCure Total Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AtriCure's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AtriCure could also be used in its relative valuation, which is a method of valuing AtriCure by comparing valuation metrics of similar companies.

AtriCure is currently under evaluation in total asset category among its peers.

AtriCure ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, AtriCure's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to AtriCure's managers, analysts, and investors.

Environmental

Governance

Social

AtriCure Institutional Holders

Institutional Holdings refers to the ownership stake in AtriCure that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of AtriCure's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing AtriCure's value.

		Shares
Geode Capital Management, Llc	2024-09-30	1.2 M
Ubs Asset Mgmt Americas Inc	2024-09-30	1 M
Gw&k Investment Management, Llc	2024-09-30	1 M
Fmr Inc	2024-09-30	973.5 K
Millennium Management Llc	2024-06-30	952.8 K
Fiera Capital Corporation	2024-06-30	918.2 K
Neuberger Berman Group Llc	2024-06-30	868.4 K
Morgan Stanley - Brokerage Accounts	2024-06-30	782.9 K
Wasatch Advisors Lp	2024-09-30	769.3 K
Vanguard Group Inc	2024-09-30	4.7 M
Blackrock Inc	2024-06-30	4.6 M

AtriCure Fundamentals

	Return On Equity	-0.0839
	Return On Asset	-0.0351
	Profit Margin	(0.09) %
	Operating Margin	(0.06) %
	Current Valuation	1.71 B
	Shares Outstanding	48.75 M
	Shares Owned By Insiders	3.18 %
	Shares Owned By Institutions	96.82 %
	Number Of Shares Shorted	1.67 M
	Price To Earning	33.47 X
	Price To Book	3.79 X
	Price To Sales	3.94 X
	Revenue	399.25 M
	Gross Profit	245.94 M
	EBITDA	(8.11 M)
	Net Income	(30.44 M)
	Cash And Equivalents	118.45 M
	Cash Per Share	2.55 X
	Total Debt	74.49 M
	Debt To Equity	0.16 %
	Current Ratio	3.66 X
	Book Value Per Share	9.54 X
	Cash Flow From Operations	4.48 M
	Short Ratio	2.50 X
	Earnings Per Share	(0.83) X
	Price To Earnings To Growth	(1.18) X
	Target Price	44.22
	Number Of Employees	1.2 K
	Beta	1.41
	Market Capitalization	1.76 B
	Total Asset	613.93 M
	Retained Earnings	(357.06 M)
	Working Capital	191.68 M
	Current Asset	74.75 M
	Current Liabilities	31.59 M
	Net Asset	613.93 M

About AtriCure Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze AtriCure's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AtriCure using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AtriCure based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:

How To Invest In AtriCure

Details

Is AtriCure Stock a good investment?

Details

What is AtriCure's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out AtriCure Piotroski F Score and AtriCure Altman Z Score analysis.

For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.

You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.83)

Revenue Per Share

9.564

Quarterly Revenue Growth

0.179

Return On Assets

(0.04)

Return On Equity

(0.08)

The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Atricure Stock Total Asset

AtriCure Company Total Asset Analysis

Total Asset

Tangible Assets

+

Intangible Assets

Current AtriCure Total Asset

AtriCure Total Asset Driver Correlations

AtriCure Total Asset Historical Pattern

AtriCure Total Assets

Total Assets

644.63 Million

AtriCure Total Asset Peer Comparison

AtriCure ESG Sustainability

AtriCure Institutional Holders

AtriCure Fundamentals

About AtriCure Fundamental Analysis

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY